RYANX
Price
$136.56
Change
-$0.81 (-0.59%)
Updated
Dec 17 closing price
RYCCX
Price
$426.65
Change
-$3.80 (-0.88%)
Updated
Dec 17 closing price
Ad is loading...

RYANX vs RYCCX

Header iconRYANX vs RYCCX Comparison
Open Charts RYANX vs RYCCXBanner chart's image
Rydex Nova A
Price$136.56
Change-$0.81 (-0.59%)
VolumeN/A
CapitalizationN/A
Rydex NASDAQ-100® 2x Strategy C
Price$426.65
Change-$3.80 (-0.88%)
VolumeN/A
CapitalizationN/A
RYANX vs RYCCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYANX vs. RYCCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYANX is a StrongBuy and RYCCX is a Buy.

FUNDAMENTALS
Fundamentals
RYCCX has more cash in the bank: 1.58B vs. RYANX (264M). RYANX pays higher dividends than RYCCX: RYANX (0.58) vs RYCCX (0.00). RYANX was incepted earlier than RYCCX: RYANX (21 years) vs RYCCX (24 years). RYANX is a more actively managed with annual turnover of: 973.00 vs. RYCCX (461.00). RYANX (2500) and RYCCX (2500) have matching initial minimum investment requirements. RYCCX annual gain was more profitable for investors over the last year : 45.37 vs. RYANX (40.00). RYCCX return over 5 years is better than : 189.14 vs. RYANX (63.24).
RYANXRYCCXRYANX / RYCCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years24 years-
Gain YTD38.85944.12488%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets264M1.58B17%
Annual Yield % from dividends0.580.00-
Returns for 1 year40.0045.3788%
Returns for 3 years9.7028.8334%
Returns for 5 years63.24189.1433%
Returns for 10 years200.46585.5134%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HESAY241.403.29
+1.38%
Hermes International SA
PRMRF20.890.01
+0.06%
Paramount Resources Ltd.
SSREY36.96-0.23
-0.62%
Swiss Re Ltd
PVCT0.13N/A
-0.66%
Provectus Biopharmaceuticals, Inc.
VDMCY5.58-0.33
-5.58%
Vodacom Group Ltd.